https://www.selleckchem.com/pr....oducts/gsk2256098.ht
Copyright © 2020 Taberna, Gil Moncayo, Jané-Salas, Antonio, Arribas, Vilajosana, Peralvez Torres and Mesía.BACKGROUND Liver cancer is the 6th most common cancer in the world and the 4th most common death from cancer worldwide. Hepatic radioembolization is a minimally invasive treatment involving intraarterial administration of radioembolic microspheres. AIM To develop a neutron-activated, biodegradable and theranostics samarium-153 acetylacetonate (153SmAcAc)-poly-L-lactic acid (PLLA) microsphere for intraarterial radioembolization o
Like
Comment
Share
